We examined whether oligodendrocytes, neurons, and astroglia derived from the human central nervous system differ in susceptibility to injury mediated by tumor necrosis factor (TNF)a and by activated CD4+ T cells acting via a TNF-independent mechanism. Injury was assessed either as cell membrane-directed (lysis), measured by Vhromiurn (Cr) or lactate dehydrogenase (LDH) release, or nucleus-directed (apoptosis), measured by morphologic features based on propidium iodide (PI) staining and by DNA fragmentation measured by a terminal transferase (TdT)-mediated dUTP biotin nick end labeling technique (TUNEL). TNF did not induce VZr or LDH release in any cell targets, but did induce nuclear (66 2 2% of cells) and DNA (68 & 2% of cells) fragmentation selectively in the oligodendrocytes over 96 hr. At this time, there was no significant loss of oligodendrocyte cell number. Nuclear injury could be induced in neurons by serum deprivation and in malignant astrocytes by the combination of TNF and low serum. CD4+ T cells activated with phytohemagglutin (pha) or anti-CD3 plus interleukin-2 induced significant 51Cr and LDH release in all target cells tested; only pha-activated CD4+ T-cell cocultures showed reduced target cell numbers. Significant nuclear fragmentation was observed only for glioma cells (22 f 1% of cells). Differences in susceptibility to different immune effector mechanisms and in the nature of the injury response to the same effector mediator among human CNS-derived neural cells will need to be considered in design of therapeutic strategies aimed at protecting or limiting target cell injury consequent to disease or trauma. [Key words: oligodendrocytes, cortical neurons, tumor necrosis factor a (TNFLu), CD4+ T cells, cytotoxicity, immune injury of CNS] Cell-mediated immune (CMI) responses are implicated as the primary mediators of tissue injury which occur in an array of inflammatory diseases of the CNS. Such responses can be mediated either by cell-cell contact-dependent or soluble factordependent mechanisms. In multiple sclerosis, myelin and its cell of origin, the oligodendrocyte (OL), are considered the major targets of this response (Bruck et al., 1994) . Pathologic and neuroimaging studies indicate that axonal injury also occurs, partic-ularly during the progressive phase of the disease (Arnold et al., 1994) . In some viral diseases, including HIV encephalopathy. immune effecters contribute to the target cell injury (Wilt et al., 1995) . Immune system products are also implicated as secondary contributors to the cellular injury in neurodegenerative disorders such as Alzheimer's disease (McGeer et al., 1989) . A specific issue raised with regard to immune mediators of tissue injury relates to whether different populations of CNS cells are selectively vulnerable to particular effecters. A corollary would be whether the mechanism of target cell injury to a common effector differs among neural cell populations. Cell injury has usually been considered in terms of primary cell membrane injury (lysis) or nuclear injury (apoptosis).
In the present study, we address these issues using dissociated in vitro cultures of human adult CNS-derived OLs, fetal CNSderived neurons and astrocytes, and human glioma cell lines as target cells. As effector mediators, we used tumor necrosis factor (TNF)-(w and in vitro-activated CD4' T cells. The former, under pathologic conditions in the CNS, may be derived both from infiltrating mononuclear cells and glial cells, both microglia and astrocytes (Robhins et al., 1987; Lee et al., 1993; . TNFa has been shown to induce DNA fragmentation of primary rodent, bovine, and human OLs after 72-96 hr of in vitro exposure (Selmaj et al., 199 I ) and of the OL precursor cell line CG4, induced to mature in vitro (Louis et al., 1993) . The related molecule TNF/3 is at least as toxic to OLs (Selmaj et al., 1991) . Gelbard et al. (1993) reported that TNFa was toxic to cultured primary human fetal cortical neurons, as assessed morphologically.
We have previously shown that mitogen-or antigen-activated CD4' T cells, the T-cell subset used to transfer autoimmune encephalitis in animals, can induce OL cell membrane injury, measured using 5'Cr or LDH release, within I8 hr of effector: target coculture . The effect is TNF-independent and non-MHC-restricted . At this time point, there is no evidence of nuclear injury, as measured by a DNA fragmentation assay (McLaurin et al., 199.5) . In the present study, we have assessed target cell responses to the T-cell effectors in terms of cell membrane and nuclear-directed injury over short (I 8 hr) and longer term (96 hr) culture. A non-MHCrestricted CD4+ T-cell effector response should be of particular interest in context of CNS cell injury, in that neither neurons or OLs to express MHC class II molecules, the restricting element for antigen-specific CD4+ T cells. by dissociation of the fetal CNS tissue with 0.05% trypsin and 50 kg/ml DNase, passing the tissue through a I32 pm nylon mesh screen, and then through a 70 urn screen. After washing with PBS, the cells were suspended in culture medium (Eagle's MEM supplemented with 5% FBS, 0.1% glucose, and I mM sodium pyruvate), and then placed into poly-t-lysine-coated 96-well microtiter wells or onto Aclar coverslips which were then placed in petri dishes (5 X IOJ cells per microwell or coverslip).
Materials and Methods

Preparation
To obtain neurons, culture dishes are first treated on day 4 in virro with I mM 5fluoro-2-deoxyuridine (5-FDU) for 2 d to deplete astrocytes; the treatment was repeated three times over a 2 week time period. These neurons are used in functional assays within I4 d. To obtain astrocytes, nontreated fetal CNS-derived dissocated cultures cultures were passaged two or three times using 0.25% trypsin for 5 min at 37°C when cultures were confluent.
Cells could be reseeded Cell memhrune-directed injury. These studies were conducted over either 5 or I8 hr using i'Chromium (Cr) release as the standard measure of cell membrane injury.
For the "Cr assay, target cells were labelled overnight with 0. In some studies, an LDH release assay (as described below) was used, although in this assay the cell source (effector or target) of released LDH would be uncertain.
For the TNFa studies, the LDH release assay was used as the standard assay at both the I8 and 96 hr time points. For this assay, culture supernatants were collected and analyzed using a commercial kit (Sigma were obtained with the TUNEL assay (42 + 3%, II = 3) ( Table  2 ). The fetal astrocytes did not undergo signilicant nuclear fragmentation (Fig. 2) or DNA fragmentation in response to either TNFa and/or low serum conditions. The overall correlation coefficient between the results of the PI assay of nuclear fragmentation and the TUNEL assay of DNA fragmentation in the above TNF assays and the CD4' T-cell effector assays described below was 0.979, n = 14.
Turget cell susceptibility to CD4' T-cell-mediated injury Membrane-directed injury. As shown in Figure 3 and Table I , the membrane-directed lytic capacity of CD4+ T cell at 24 hr was found to be dependent on the method of T-cell activation. Pha-activated CD4+ T cells induced significant "Cr release from each of the neural cell targets, with release being highest in the proliferating cell targets (fetal astrocytes and glioma cells). These results were confirmed in the LDH assay (Table I) . Significant loss of both OLs and glioma cells, the only two target cells examined, was observed following their exposure to the pha-activated CD4+ T cells (Table I) . Pha-activated CD4+ Tcell-mediated "Cr release could be detected as early as 5 hr in effector:target cocultures (data not shown).
CD4+ T cells activated with anti-CD3 and IL-2 also induced significant riCr release from all neural cell targets tested in the I8 hr assay, with no apparent differences amongst the targets in their relative suceptibilities (Fig. 3 ). Significant cell loss could not be detected for either the OLs or gliomas (Table 2 ). CD4' T cells activated by anti-CD3 alone did not induce significant 5'Cr release from neurons, astrocytes, or glioma cells (Fig. 3) . A low and variable level of OL-directed cytotoxicity was found. Studies using glioma cells as targets indicated that anti-CD3-activated T cells could induce 51Cr release of previously resistant targets if the effector cells were coated with pha just prior to being added to the previously "resistant" target cells (6 5 5% for uncoated vs I9 2 2% for pha-coated anti-CD3-activated effectors, n = 2).
'H-thymidine uptake was comparable between CD4' T cells activated by pha (34226 ?Z 5591 cpm, n = 4) or anti-CD3 (38355 cpm -C 5534, n = 4); uptake by anti-CD3 and IL-2-activated cells was significantly higher (59252 ? 7788 cpm, II = 4, p < 0.05). Purity of CD4+ T cells did not differ as a function of activation conditions (mean percent CD4' T cells derived from anti-CD3-activated cultures was 89 2 3%; from anti-CD3 plus IL-2-activated cultures 87 + 3%: and, from phaactivated cultures 92 -C 2%. n = 7) as assessed using flow cytometry. There were less than 2% CD8+ T cells or NK cells.
Total 5'Cr labelling of the various cell targets used did not vary widely (for OLs: 5000-7000 cpm; for neurons: 2500-3000 cpm; for astrocytes and glioma cells: 6000-8000 cpm). Nonspecific release was comparable among the neural cells, with a mean range of 26-33%.
These values are higher than those found using a 5 hr cr51 release assay.
Nucleus-directed injury. Although all target cells released "Cr upon coculture with pha-activated CD4' T cells, only in the glioma cells was there a significant increase in the proportion of fragmented nuclei compared to control cultures, as measured either by PI staining or TUNEL technique (Fig. 2, Table 2 ). The proportion was increased as early as I8 hr, with a further increase by 96 hr.
Discussion
We have utilized dissociated cultures of human CNS-derived cells to examine the relative susceptibility of these cells to TNF- 
Results
Properties of turget cells The morphologic and/or immunocytochemical features of the neural cells used in this study are illustrated in Figure I . Purity of the OLs in enriched cultures was estimated at 80-90% during the 24 week culture period. Contaminating cells included astrocytes and tibroblasts. The latter overgrew the culture over longer time periods. The fetal cortical neurons were estimated to comprise 80-90% of cells in their cultures, with GFAP' astrocytes being the other cell type. Although only immunoreactivity with MAP 2 mAb is illustrated, these cells could be immunostained with anti-neurohlament, anti-NSE, and anti-Tau mAbs. The U25l glioma line has lost GFAP immunoreactivity.
Turget cell susceptibility to TNFa-mediated injury
Mernbrune-directed injuty. Levels of LDH measured in supernatant of 5% serum-supplemented cultures of OLs, neurons, and astroglia did not differ between those which did or did not contain TNFo (Table I) .
Nucleus-directed injury. Addition of a single dose of 1000 units of TNFo to 5% serum-supplemented OL-enriched cultures resulted in nuclear fragmentation in a significant proportion of OLs at 96 hr (66 -t 3%, n = 6) compared to control cultures (7 2 0.6Y0, p < 0.01) by PI criteria (Fig. 2) . A similiar proportion of OLs (68 -+ 2%) showed DNA fragmentation as determined by TUNEL assay (Fig. I, Table 2 ). This effect was not apparent at 24 hr. The proportion of OLs showing TNFa-induced nuclear fragmentation at 96 hr was significantly greater than that induced by serum deprivation (43 2 3%, n = 6, p < 0.01). The number of OLs remaining in the TNF-treated and nontreated cultures after 96 hr did not differ significantly (Table I) .
The proportion of fragmented nuclei in neurons exposed to TNF for 96 hr was significantly increased over control values (IO 2 1% vs 6 + 0.4%, n = 7, p < 0.01). This proportion was, however, markedly lower than that for OLs and significantly lower than that induced by serum deprivation (25 -C 3%, n = 7, p < O.OOl).
The proportion of fragmented nuclei in glioma cells was not significantly increased in cultures containing 5% serum plus 1000 U/ml of TNFa (7 + 0.9%, n = 6) compared to control values (5 ? 0.6%, n = 6) (Fig. 2) . Serum deprivation alone augmented nuclear fragmentation only to a small extent (I2 ? 2%, n = 3). Fragmentation of nuclei could be more readily observed in these cells by combining reduced serum conditions (1%) and TNFa (35 + 3%, n = 5, p < 0.001). Similiar results . Susceptibility of human neural cells to TNFo-induced nuclear injury, propidium iodide (PI) assay; bars indicate percentage -C SEM of OLs, neurons, glioma, and fetal astrocytes which show morphologic features of nuclear fragmentation after 96 hr in tissue culture medium containing either 5% FCS, 5% FCS plus 1000 U/ml TNFa, 1% FCS, 1% FCS plus TNFa, or no serum. Solid porfions of bars indicate percentage of cells with fragmented nuclei found at 18 hr. For each test condition the number of coverslips counted is indicated. At least two invdividual experiments were performed for each condition. and non-TNF-dependent effector mechanisms, the latter mediated by activated CD4+ T cells acting in a non-MHC-restricted manner. The target response was assessed in terms of the two major categories of cell injury, namely primary cell membranedirected injury (lysis) and nucleus-directed injury (apoptosis) (Zychlinsky et al., 1991; Taylor and Cohen, 1992; Cohen, 1993; Louis et al., 1993; Schwartzman and Codlowski, 1993) , and in terms of the time required for the response to develop. The resuits indicated that the target cells studied (OLs, neurons, and malignant and nonmalignant astrocytes) differed in their relative susceptibilities to these effector mechanisms and in the nature of the cellular injury which occurred.
The susceptibility of human adult CNS-derived OLs to the nuclear injury-inducing effects of TNFcx that we found in our (Selmaj et al., 1991; Louis et al., 1993) . Over the same time period, we did not detect significant cell membrane rupture, as assessed using "Cr or LDH release, nor loss of cell numbers. The latter results are consistent with those of Zajicek et al. (1992) who found that soluble human recombinant TNFa did not induce cytotoxicity of rodent OLs, whereas cell-bound TNF was the putative mediator of microgha-induced cytotoxicity of OLs in vitro. In contrast to the OLs, the neurons, in our study, were relatively resistant to TNFo in terms of nuclear injury. The extent of TNFo-induced nuclear injury of OLs was greater than that induced by serum deprivation; the reverse was observed for the human fetal neurons. Giulian et al. (1993) previously observed the greater susceptibility of neurons, compared to OLs, to noncytokine low molecular weight factors released by microglia.
Neither the malignant nor nonmalignant fetal astrocytes showed significant nuclear injury in response to TNFa under our usual culture conditions.
In addition, we did not observe significant nuclear or DNA fragmentation in the small proportion of astrocytes contained in our adult CNS-derived OL-enriched cultures. These results indicate the differences in susceptibility to a common effector between glial cells of apparently shared developmental lineage (Barres et al., 1992) . The ghoma cells, but not the nonmalignant astrocytes, showed significant nuclear and DNA fragmentation in response to the combination of serum deprivation and TNFa. The ghoma cells had a higher rate of proliferation than did the fetal astrocytes; the proliferation of the latter was higher than that of the adult CNS-derived astrocytes . The adult astrocytes can be shown to incorporate significant levels of BrdU in vitro in contrast to the OLs (Grenier et al., 1989) . NEL). A strong correlation was found between results in the two assays. The numbers of OLs and neurons available and difficulties in recovering these cells from cultures limited the use of other techniques to assess DNA fragmentation, such as DNA Nuclear injury was assessed using morphologic criteria of PIstained cells and a fluorescence DNA fragmentation assay (TUas targets (Pate1 et al., 1987; Thiele and Lipsky, 1989) . The CD4' T cells activated by anti-CD3 alone did possess cytotoxic potential, as revealed by coating these cells with pha immediately prior to adding them to target cells. IL-2 augmented cytotoxicity mediated by anti-CD3-activated T cells has previously been described (Stohl et al., 1990; Nishimura et al., 1992) . The lack of cytotoxicity found using CD4' T cells activated with anti-CD3 alone, compared to anti-CD3 plus IL-2, suggests that residual anti-CD3 antibody on the T cells is not serving as a hgand. The essential ligands involved in promiscuous T-cell killing of particular cell targets remains to be dehned.
Extent of T-cell proliferation as a function of method of T-cell activation did not correlate with cytotoxicity, in that 'H-thymidine uptake was similar between anti-CD3-and pha-activated T cells. T cells activated with anti-CD3 and IL-2 showed the highest proliferation rates. However, even at a 2O:l E:T ratio, CD4' T cells activated by anti-CD3 alone did not induce the extent of 5'Cr release found using anti-CD3 plus IL-2-activated CD4+ T cells at a lower E:T ratio (data not shown), suggesting that differences in effector cell numbers that may have occurred during the co-culture period did not account for the functional results. Any remaining exogenous IL-2 in the anti-CD3 plus IL-2-activated cultures would have been removed at the time the T cells were washed prior to adding them to the cell targets. The T-cell populations used were highly enriched for CD4+ T cells, and thus the effects induced are unlikely to be due to a small population of NK cells (Galandrini et al., 1994) . Mechanisms of CD4+ o/B T-cell receptor (TcR) bearing T-cell-mediated cytotoxicity may differ from those used by other T-cell populations, including CD8+ T cells and y/6 TcR-bearing T cells (Smyth, 1992) . depletion-induced fragmentation to occur. Cell numbers were reduced in all cell cultures exposed to pha-treated CD4+ T cells. The lack of DNA and nuclear fragmentation in the nonglioma neural cells would seem to differ from previous studies of CD4+ With regard to the target cell response to pha-activated T cells, only in the glioma cells did DNA and nuclear fragmentation develop. Significant fragmentation was observed within 18 hr, a time period which precedes that required for TNFcx and serum ladders or FACS analysis. The former would have limited use in the coculture systems discussed below, containing both effector and target cells.
Target cell injury mediated by CD4+ T cells depended both on the means of T-cell activation and the cell type serving as the target. Pha-activated CD4+ T-cell lysis could be detected in 5 hr as well as 18 hr cocultures, suggesting that these cells had residual surface lectin, and their effect was akin to lectin-dependent cell cytotoxicity (Bevan and Cohen, 1975; Ruijs et al., 1990) . Our previous studies indicated that the effect was not mediated via TNF-dependent mechanisms, in that it could not be blocked with neutralizing anti-TNF antibody or reproduced with TNF . CD4+ T cells have previously been demonstated to be capable of mediating both TNF-dependent and -independent cytotoxicity (Ju et al., 1990; Liu et al., 1992; Smyth et al., 1992) . CD4+ T cells activated by anti-CD3 and IL-2 induce membrane injury to a greater extent in the 18 hr than in the 5 hr T-cell-mediated cytotoxicity using non-neural cell targets, in that the latter suggested that nuclear injury preceded cell disintegration (reviewed in Thiele and Lipsky, 1989; Duke, 1992; Grogg et al., 1992; Berke, 1994; Stalder et al., 1994) . The glioma cells are the most actively proliferating of the cell targets used in our study. Our data suggests that primary non-dividing CNS cells, OLs, and neurons, are resistant to this pathway, although they are capable of undergoing apoptosis as shown using either TNF or serum deprivation. These data would be consistent with the existence of multiple different pathways whereby nuclear injury programs are activated (Rose and Henneberry, 1993; Schwartz et al., 1993; Schwartzman and Cidlowski, 1993; Oltavi and Korsmeyer, 1994) .
Cell membrane injury mediated by the anti-CD3-activated CD4+ T cells was not accompanied by either the extent of DNA fragmentation (in the case of gliomas) or cell loss (found with all cell targets tested) observed using the pha-activated T cells. These findings could provide a model whereby T cells could cytotoxicity assays (Ruijs et al., 1990) . The cytotoxic effect of induce membrane injury without necessarily cell body loss, that anti-CD3 plus IL-2-activated CD4+ T cells would seem akin to is, sublethal injury with potential for recovery, as suggested for that initially termed promiscuous killing in assay systems using complement-mediated injury (Scolding et al., 1989) . Our preeither antigen or anti-CD3 and IL-2 to generate T-cell lines as vious studies did indicate that human OLs are susceptible to effecters and dividing non-neural NK cell-resistant tumor lines promiscuous cell-mediated cytotoxicity mediated by-MBP re-active CD4+ T-cell lines . In the case of multiple sclerosis, the issue of myelin loss, with or without OL cell loss, continues to be studied (Bruck et al., 1994) . In summary, our current in vitro data indicate the differing susceptibility and cellular response of human CNS neural cells to TNF-dependent and independent immune effector mechanisms. Therapeutic strategies applied to diseases or injury of the human CNS will need to consider this heterogeneity.
